Skip to main content
Premium Trial:

Request an Annual Quote

Lion, Silicon Genetics to Integrate Software

NEW YORK, June 3 - Silicon Genetics and Lion Bioscience said today that they have begun a multi-year joint development and marketing collaboration centered around the integration of their software products: Silicon Genetics' GeneSpring and Lion's SRS and Target Engine.


Initially, the integration will allow users of the GeneSpring gene expression analysis platform to access data stored in Lion's SRS integration platform. This will allow scientists to include information from both public and proprietary sources in their gene expression analysis, the companies said.


Lion will also integrate GeneSpring software with its upcoming Target Engine drug discovery software platform, and will be able to co-market GeneSpring along with SRS and Target Engine.


Click here to see the full announcement.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.